AVODART CAP

160.00 EGP

each capsule for oral use contains 0.5 mg dutasteride .

AVODART CAP; dutasteride, genitourinary agents .

ACTIVE-INGREDIENT OF AVODART CAP

each capsule for oral use contains 0.5 mg dutasteride .

INDICATION OF AVODART CAP

avodart treats and prevents progression of benign prostatic hyperplasia (BPH) through alleviating symptoms , reducing prostate size ( volume ) , improving urinary flow rate and reducing the risk of acute urinary retention (AUR) and the need for BPH- related surgery . avodart in combination with the alpha – blocker tamsulosin , treats and prevents progression of benign prostatic hyperplasia (BPH) by reducing prostate size , alleviating symptoms , improving urinary flow rate and reducing the risk of acute urinary retention (AUR) and the need for BPH- related surgery .

DOSAGE OF AVODART CAP

Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet

Ask your pharmacist or doctor for help if you do not understand the instructions on the box .

The recommended dose is : –

adult meals ( including elderly ) : capsules should be swallowed whole and not chewed or opened , as contact with the capsule contents may result in irritation of the oropharyngeal mucosa . Avodart may be taken with or without food . The recommended dose of avodart is one capsule ( 0.5 mg ) taken orally once a day . although an improvement may be observed at an early stage , treatment for at least 6 months may be necessary in older to assess objectively whether a satisfactory response to the treatment can be acieved . for treatment of BPH , avodart can be administered alone or in combination with the alpha-blocker tamsulosin ( 0.4 mg ) . renal impairment : the effect of renal impairment on dutasteride pharmacokinetics has not been studied . however , no adjustment in dosage is anticipated for patients with renal impairment . hepatic impairment : the effect of hepatic impairment on dutasteride pharmacokinetics has not been studied .

OVER-DOSAGE OF AVODART CAP

in volunteer studies single doses of dutaseride up to 40 mg/day ( 80 times the therapeutic dose ) for 7 days have been administered without significant safety concerns . In clinical studies doses of 5 mg daily have been administered to patients for 6 months with no additional adverse effects to those seen at therapeutic doses of 0.5 mg . there is no specific antidote for dutasteride therfore , in cases of suspected overdosage , symptomatic and supportive treatment should be given as appropriate .

CONTRA-INDICATION OF AVODART CAP

avodart is contrindicated in patients with known hypersensitivity to dutasteride , other 5 alpha -reductase inhibitors , or any component of the preparation . Avodart is contraindicated for use in women and children and adolescents . Avodart is contraindicated in patients with severe hepatic impairment .

STORAGE OF AVODART CAP

do not store above 30° C .
PACK OF AVODART CAP
pack of 3 strips , each of 10 capsules .
AVODART CAP MANUFACTURED BY
GLAXOSMITHKLINE

https://www.drugs.com/mtm/dutasteride.html

https://www.gardeniapharmacy.com/category/medicine-2/

Form

Gender

How to use

Reviews

There are no reviews yet.

Show reviews in all languages (1)

Be the first to review “AVODART CAP”

Your email address will not be published. Required fields are marked *

Shopping Cart
Don`t copy text!
Scroll to Top
Open chat